| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida; the 2 Department of Ophthalmology, Virchow-Charité Hospital, Humboldt-University of Berlin, Berlin, Germany; the 3 Department of Ophthalmology, University of Innsbruck, Innsbruck, Austria; the 4 Department of Ophthalmology, CHU Sart-Tillman, University of Liege, Liege, Belgium; and the 5 Department of Ophthalmology, Hôtel-Dieu Hospital, University of Paris, Paris, France.
PURPOSE. To evaluate the pharmacokinetics and safety of aspirin delivered by a single, noninvasive, transscleral, coulomb-controlled iontophoresis (CCI) treatment; topical application; or by one intravenous (IV) injection.
METHODS. Forty-one adult New Zealand White rabbits received either a single IV injection, topical, or CCI administration of aspirin at a concentration of 10 mg/mL. Histologic evaluation was performed in four CCI-treated eyes to assess safety. Pharmacokinetic distribution in all ocular tissues and fluids was studied at 0.5, 1, 2, 4, 6, and 8 hours after the treatments. Immediately after death, the eyes were dissected and salicylic acid (SA) concentration was determined by HPLC analysis. Blood was sampled at 0.5, 1, 2, 4, 6, and 8 hours, and plasma SA levels for systemic distribution were measured by HPLC analysis.
RESULTS. No tissue damage was observed clinically or histologically. SA was found in all tissues and fluids throughout the study period of 8 hours. The highest concentrations of SA were observed with CCI immediately after treatment for all tissues and were the highest SA tissue peaks obtained by the studied delivery methods. IV administration demonstrated a delayed tissue peak of salicylate at 2 hours after administration. At 8 hours, ocular SA concentrations were in the same range for CCI and IV administration. IV injection resulted in blood plasma levels up to 28 times higher than CCI and remained significantly elevated until 8 hours after the treatments.
CONCLUSIONS. CCI is a safe and effective method of administering aspirin to the eye while avoiding the systemic side effects associated with IV injection.
This article has been cited by other articles:
|
|
 |
|
  L. Zheng, S. J. Howell, D. A. Hatala, K. Huang, and T. S. Kern Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy Diabetes, February 1, 2007; 56(2): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hayden, M.-E. Jockovich, T. G. Murray, M. T. Kralinger, M. Voigt, E. Hernandez, W. Feuer, and J.-M. Parel Iontophoretic delivery of Carboplatin in a murine model of retinoblastoma. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3717 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Horwath-Winter, O Schmut, E-M Haller-Schober, A Gruber, and G Rieger Iodide iontophoresis as a treatment for dry eye syndrome Br. J. Ophthalmol., January 1, 2005; 89(1): 40 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Hayden, M.-E. Jockovich, T. G. Murray, M. Voigt, P. Milne, M. Kralinger, W. J. Feuer, E. Hernandez, and J.-M. Parel Pharmacokinetics of Systemic Versus Focal Carboplatin Chemotherapy in the Rabbit Eye: Possible Implication in the Treatment of Retinoblastoma Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3644 - 3649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Li, E.-K. Jeong, and M. S. Hastings Magnetic Resonance Imaging Study of Current and Ion Delivery into the Eye during Transscleral and Transcorneal Iontophoresis Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1224 - 1231. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
